We are live on ! Find out more
LP

Longview Partners Portfolio holdings

AUM $6.16B
1-Year Est. Return 3.55%
This Fund
S&P 500
This Quarter Est. Return
-6.82%
1 Year Est. Return
+3.55%
3 Year Est. Return
+35.76%
5 Year Est. Return
+55.83%
10 Year Est. Return
+255.17%
AUM
$14.2B
AUM Growth
-$1.08B
Cap. Flow
+$134M
Cap. Flow %
0.94%
Top 10 Hldgs %
46.57%
Holding
26
New
2
Increased
–
Reduced
24
Closed
–

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$668M
2
ZBH icon
Zimmer Biomet
ZBH
+$329M

Top Sells

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$209M
2
UNH icon
UnitedHealth
UNH
+$132M
3
ACN icon
Accenture
ACN
+$106M
4
APTV icon
Aptiv
APTV
+$92.8M
5
FISV
Fiserv Inc
FISV
+$74.7M

Sector Composition

Rank Sector Weight
1 Technology 25.11%
2 Financials 22.3%
3 Healthcare 19.81%
4 Consumer Discretionary 13.71%
5 Industrials 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVT icon
26
Avnet
AVT
$8.18B
$159M 1.12%
3,719,389
-41,428
-1% -$1.72M
1
2

Similar funds

SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
MF
Milford Funds Auckland $6.14B AUM
SLI
Sumitomo Life Insurance Tokyo, Japan $6.12B AUM 21.82% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
EQF
Evergreen Quality Fund Grand Cayman, Cayman Islands $6.2B AUM 288.56% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Longview Partners's Q3 2015 Portfolio in Review

As of Q3 2015, Longview Partners held 26 positions worth $14.2B, down 7.1% from $15.2B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Longview Partners's Q3 2015 filing shows 2 new and 24 reduced positions. Its largest new stake was Thermo Fisher Scientific: 5,125,175 shares worth $627M. The largest sale was Fidelity National Information Services, an estimated $209M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • Longview Partners's largest Q3 2015 buy was Thermo Fisher Scientific: 5,125,175 shares worth $627M.
  • Longview Partners's biggest Q3 2015 reduction was Fidelity National Information Services, cutting an estimated $209M.
  • Longview Partners's ten largest holdings make up 47% of its $14.2B portfolio in Q3 2015.
  • Longview Partners opened 2 new positions and closed 0 in Q3 2015.
  • Longview Partners's portfolio value fell 7.1% quarter-over-quarter to $14.2B.

Based on Longview Partners's 13F filing for Q3 2015, filed 2 Nov 2015.